Women and Children as the Focus for Control of Schistosomiasis Infections in the Irrigations Area of Burkina Faso

Learn more about:
Related Clinical Trial
Correlating Protection Against Malaria With Serum Profiles Against Plasmodium Falciparum Antigen Repertoires Prevalence of Chronic Kidney Disease (CKD) and Risk Factors in Sub-Saharan Africa S. Japonicum and Pregnancy Outcomes Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, Ghana Study of Safety and Immune Response of the Sm14 Vaccine in Adults of Endemic Regions L-praziquantel Orodispersible Tablets (L-PZQ ODT) in Schistosoma Infected Children The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda Praziquantel in Children Under Age 4 Schistosoma Haematobium Infections and Praziquantel Antioxidant Supplements in the Reversal of Schistosomal Peri-portal Fibrosis Single-sex Controlled Human Schistosomiasis Infection: Safety and Dose Finding A Phase Ib Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel)(R) With or Without AP 10-701 for Intestinal Schistosomiasis in Healthy Exposed Adults Single-sex Female Controlled Human Schistosomiasis Mansoni Infection An Open Label Dose Finding Safety and Efficacy in Children and Infants Infected With Schistosomiasis (S.Mansoni) Schistosomiasis Effect on Response to Vaccines, Anaemia and Nutritional Status of Children of Northern Senegal Praziquantel-Pharmacokinetic Study Schistosomiasis in Women of Reproductive Age in Burkina Faso: Implications for Control Iron Supplementation in Schistosomiasis and Soil Transmitted Helminths Control Programmes in Zambia Schistosomiasis in Formal and Non-Formal Schools in Uganda: Implications for Control Programmes Using Community-Based Volunteers to Reach Non-Enrolled School Aged Children Through Community-Directed Treatment of Schistosomiasis in School-Aged Children in Rural Northern Ghana Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults Clinical Trial of Bilhvax,a Vaccine Candidate Against Schistosomiasis A Phase I Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without GLA-AF for Intestinal Schistosomiasis in Healthy Adults Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study Schistosomiasis in Senegal Repeated Doses of Praziquantel in Schistosomiasis Treatment (RePST) Childhood Schistosomiasis: a Novel Strategy Extending the Benefits/Reach of Antihelminthic Treatment Anti-Schistosomiasis Vaccine: Sm14 Phase 2b-Sn in School Children Study to Evaluate the Safety of the Vaccine Prepared sm14 Against Schistosomiasis Arachidonic Acid Treatment Against Schistosomiasis Infection in Children Detection of Schistosomiasis CAA in Travellers After High-risk Water Contact Evaluation of Strategies for Improved Uptake of Preventive Treatment for Intestinal Schistosomiasis Health Benefits of Repeated Treatment in Pediatric Schistosomiasis Seropositivity and Adverse Birth Events in Migrants From Bilharzia-endemic Areas Women and Children as the Focus for Control of Schistosomiasis Infections in the Irrigations Area of Burkina Faso

Brief Title

Women and Children as the Focus for Control of Schistosomiasis Infections in the Irrigations Area of Burkina Faso

Official Title

Women and Childres at the Focal Point for the Schistosomiasis Control and Sustainability and Effectiveness in the Hydro Agricultural Zone of Sourou, Burkina Faso

Brief Summary

      The purpose of this study is to examine the extent of schistosomasis infections in women and
      children, their daily activites that encumber contact with water and their knowledge and
      attitudes towards the prevention of schistosomiasis.

      The hypothesis that will be explored is that women and children spent more time with
      agricultural and household activities which bring them in contact with water and therefore
      give them an increased risk of being infected by schistosoma. Prevention and control of
      schistosomiasis has to be focusing on women and children.
    

Detailed Description

      The study will be carried out in and irrigation area of Burkina Faso where people relay on
      water. The study applies several methodes;

        1. Parasitological survey: From thre villages 200 women and children are randomly sampled
           to have their urin and stool examined for parasittes.

        2. Observations: At each village sites at the irrigation canals where people meet and have
           their activities observations of the kind and the duration of watercontact will be
           observed.

        3. Focus group interview: In each village 5 focus group interviews will be conducted with 6
           to 12 participants in each group

        4. Individual interviews: for the participant in the focus group interview a total of 45
           participants will be selected for indept individual interviews

        5. Questionnaire: a total of 360 questionnairs will be distributed to participants in the
           parasitological survey, the focus group interviews and to participants who did not
           participate in any of the above mentioned.

      Participants will be women and children from the three villages.
    


Study Type

Observational




Condition

Schistosomiasis



Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information



Estimated Enrollment

360

Start Date

December 2006

Completion Date

February 2007


Eligibility Criteria

        Inclusion Criteria:

        Women and children from three villages
      

Gender

Female

Ages

N/A - N/A

Accepts Healthy Volunteers

Accepts Healthy Volunteers

Contacts

Jean N Poda, Ph.d.,M.Sc., , 



Administrative Informations


NCT ID

NCT00463528

Organization ID

SRP-BF-JNP-05



Study Sponsor

DBL -Institute for Health Research and Development


Study Sponsor

Jean N Poda, Ph.d.,M.Sc., Principal Investigator, Institute of Health Sciences Research, Burkina Faso


Verification Date

July 2007